search
Back to results

A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts (EVAADE)

Primary Purpose

Haematological Malignancy, Acute Leukemia, Myelodysplastic Syndromes

Status
Withdrawn
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Physical activity program
Sponsored by
Centre Leon Berard
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Haematological Malignancy

Eligibility Criteria

8 Years - 21 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 8 years ≤ Age ≤ 21 years
  • Size more or equal to 110 cm.
  • Histologically or cytologically confirmed malignant or non-malignant haemopathy
  • Indication for hematopoietic stem cell allograft.
  • Hospitalization in a protected room at IHOP/DAJAC.
  • Certificate of no contraindication to the practice of an APA, issued by the oncologist or attending physician.
  • Having available in the sterile room a smartphone (iPhone 5S version for Apple/version 5 under Android at least) or a tablet (for the realization of the connected challenges) during the whole hospitalization period.
  • Written consent signed and dated by the patient or the parents of minor patients with the acceptance of the minor.

Exclusion Criteria:

  • Severe Heart Disease and Uncontrolled Cardiovascular Disease

Sites / Locations

  • Institut d'Hématologie et d'Oncologie Pédiatrique

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Physical activity intervention

Arm Description

The intervention consists of an adapted physical activity (APA) program defined at baseline, incorporating supervised sessions with an APA teacher, as well as autonomous sessions. The program is individualized according to age, aerobic capacity, and PA preferences. The total duration of the intervention is a maximum of 3 months (during the period of hospitalization in a sterile room).

Outcomes

Primary Outcome Measures

Observance to the physical activity program
achieved/non-achieved (achived meaning the patient attended at least one session of 15 minutes weekly during the whole program

Secondary Outcome Measures

Impact of the physical activity program on weight
weight in kgs
Impact of the physical activity program on waist circumference
assessed in cm
Impact of the physical activity program on hip circumference
assessed in cm
Impact of the physical activity program on abdominal circumference
assessed in cm
Impact of the physical activity program on body mass index
weight/(size)2
Impact of the physical activity program on endurance capacity
Harvard step test
Impact of the physical activity program on muscle strength
Dynamometer
Impact of the physical activity program on fatigue
Visual analogic scale from 0 to 10
Self-efficacy feeling
HAPA questionnaire
Motivation towards physical activity
BREQ questionnaire
Impact of the PA program on metabolic syndrome
Lipid check-up

Full Information

First Posted
March 31, 2020
Last Updated
February 10, 2022
Sponsor
Centre Leon Berard
search

1. Study Identification

Unique Protocol Identification Number
NCT04331483
Brief Title
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
Acronym
EVAADE
Official Title
A Feasibility Study to Assess Connected Bikes as a Means of Adapted Physical Activity in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Withdrawn
Why Stopped
modification of the intervention before patient's enrollment, new protocol submitted
Study Start Date
December 8, 2018 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
September 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Leon Berard

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To date, allogeneic haematopoietic stem cell transplantation (aHSCT) is the only curative treatment for many paediatric and young adult haematological pathologies (acute leukaemia, myelodysplastic syndromes, haemoglobinopathies, bone marrow aplasia, severe combined immunodeficiency). Despite the major therapeutic progress made over the last 50 years, particularly in terms of supportive care, post-transplant morbidity and mortality remains high. Infectious complications, whose incidence varies between 30 and 60%, are the first cause of mortality in the immediate post-transplant period. In order to protect the patient from the occurrence of severe infectious episodes, aHSCTmust be performed in a highly protected environment (positive pressure chambers). This has implications for the experience and impact of hospitalization on the patient and family. This is particularly true in paediatrics, whether in children, adolescents or young adults, where it is not only the patient's quality of life that is at stake, but also their emotional and psychomotor development. In these patients, prolonged hospitalization (at least 6 weeks) in a sterile room will be responsible for physical deconditioning accompanied by a decrease in muscle mass, itself concomitant with undernutrition, and an increase in sedentary lifestyle. This prolonged hospitalisation in a sterile room, associated with myeloablative treatments, is therefore the cause of social isolation of patients, but it is also often synonymous with physical inactivity leading to a rapid decrease in physical condition, quality of life and an increase in fatigue. Today, the benefits of physical activity (PA) during and after cancer treatment have been widely demonstrated. The objective is to evaluate the feasibility of an adapted physical activity program during the isolation phase for achieving aHSCT in children, adolescents and young adults. This is a prospective, interventional, monocentric cohort study conducted at the Institute of Paediatric Haematology and Oncology in Lyon. The intervention will take place during the isolation phase and consists of an adapted physical activity (APA) program defined at inclusion, integrating supervised sessions with an APA teacher, as well as autonomous sessions. The program is individualized according to age, aerobic capacity, and PA preferences. Sessions are also tailored to the biological, psychological, and social parameters of patients. The total duration of the intervention is 3 months. To date, no PA studies have been performed in patients under 21 years of age requiring aGCSH during the sterile isolation phase. EVAADE will therefore be the first study in this population to offer an innovative procedure with a connected device.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Haematological Malignancy, Acute Leukemia, Myelodysplastic Syndromes, Hemoglobinopathy in Children, Bone Marrow Aplasia, Severe Combined Immunodeficiency

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physical activity intervention
Arm Type
Experimental
Arm Description
The intervention consists of an adapted physical activity (APA) program defined at baseline, incorporating supervised sessions with an APA teacher, as well as autonomous sessions. The program is individualized according to age, aerobic capacity, and PA preferences. The total duration of the intervention is a maximum of 3 months (during the period of hospitalization in a sterile room).
Intervention Type
Other
Intervention Name(s)
Physical activity program
Intervention Description
Supervised sessions of at least 15 minutes 4 times a Week combined with unsupervised sessions. The supervised activities include moderate-intensity aerobic activities (exercise bike), muscle strengthening (dumbbells, elastic bands, medicine balls) and playful situations (ball games, cooperative games, body expression games). Each patient can also do unsupervised sessions, autonomously, on the bike thanks to a smartphone application developed by the Kiplin company, with challenges to be carried out by teams of 2 to 5 people (team including several patients, possibility to include relatives) over periods of 1 to 3 weeks per challenge.
Primary Outcome Measure Information:
Title
Observance to the physical activity program
Description
achieved/non-achieved (achived meaning the patient attended at least one session of 15 minutes weekly during the whole program
Time Frame
weekly from baseline to 3 months
Secondary Outcome Measure Information:
Title
Impact of the physical activity program on weight
Description
weight in kgs
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on waist circumference
Description
assessed in cm
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on hip circumference
Description
assessed in cm
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on abdominal circumference
Description
assessed in cm
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on body mass index
Description
weight/(size)2
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on endurance capacity
Description
Harvard step test
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on muscle strength
Description
Dynamometer
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the physical activity program on fatigue
Description
Visual analogic scale from 0 to 10
Time Frame
Baseline, 1 month and 3 months
Title
Self-efficacy feeling
Description
HAPA questionnaire
Time Frame
3 months
Title
Motivation towards physical activity
Description
BREQ questionnaire
Time Frame
Baseline, 1 month and 3 months
Title
Impact of the PA program on metabolic syndrome
Description
Lipid check-up
Time Frame
Baseline and 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 8 years ≤ Age ≤ 21 years Size more or equal to 110 cm. Histologically or cytologically confirmed malignant or non-malignant haemopathy Indication for hematopoietic stem cell allograft. Hospitalization in a protected room at IHOP/DAJAC. Certificate of no contraindication to the practice of an APA, issued by the oncologist or attending physician. Having available in the sterile room a smartphone (iPhone 5S version for Apple/version 5 under Android at least) or a tablet (for the realization of the connected challenges) during the whole hospitalization period. Written consent signed and dated by the patient or the parents of minor patients with the acceptance of the minor. Exclusion Criteria: Severe Heart Disease and Uncontrolled Cardiovascular Disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carine HALFON-DOMENECH, MD
Organizational Affiliation
Institut d'Hematologie et d'Oncologie Pédiatrique
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut d'Hématologie et d'Oncologie Pédiatrique
City
Lyon
ZIP/Postal Code
69008
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts

We'll reach out to this number within 24 hrs